News

News

No. Title Written by Date Read
8 STCube and Samsung Biologics Enter into Development and Manufacturing Agreement for Novel Target Anticancer Drug Admin 20.03.03 413
7 STCube Obtains EU Patent for Screening Method for Cancer Immunotherapy Candidates Using Radiation Admin 19.11.28 3,614
6 STCube Attracts Investment of 42 Billion Won, “Accelerating Development of Anti-cancer Immunotherapies Admin 18.04.25 325
5 A Road to Conquering Cancer — Successful Development of Antibody Drug as Potential Cure for Difficult-to-Treat Cancer Admin 18.02.13 323
4 Global Patent Application Made for STCube’s Novel Anti-cancer Immunotherapy Admin 17.11.23 287
3 STCube to Collaborate with U.S. Based Diviner Therapeutics for New Development of Novel Anticancer Immunotherapeutics Admin 17.10.31 267
2 STCube Completes Early-Stage License Out of its PD-L1 Antibodies in China and Taiwan Admin 17.10.19 260
1 STCube Publishes in the July Issue of The Journal Of Thoracic Oncology Admin 14.07.23 261